tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Acumen first participant dosed in OLE portion of Phase 2 ALTITUDE-AD trial
PremiumThe FlyAcumen first participant dosed in OLE portion of Phase 2 ALTITUDE-AD trial
2M ago
Acumen Pharmaceuticals Reports Q3 2025 Financial Results
Premium
Company Announcements
Acumen Pharmaceuticals Reports Q3 2025 Financial Results
2M ago
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
Premium
Company Announcements
Acumen Pharmaceuticals’ Earnings Call: Progress and Challenges
2M ago
Acumen appoints George Golumbeski as chairman of the board
PremiumThe FlyAcumen appoints George Golumbeski as chairman of the board
3M ago
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Acumen price target lowered to $4 from $11 at BTIG
Premium
The Fly
Acumen price target lowered to $4 from $11 at BTIG
3M ago
Acumen reports Q2 EPS (68c), consensus (52c)
PremiumThe FlyAcumen reports Q2 EPS (68c), consensus (52c)
6M ago
Acumen sees cash runway into early 2027
Premium
The Fly
Acumen sees cash runway into early 2027
6M ago
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ABOS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100